This innovative approach, termed INSCRIBE, employs the versatile CRISPR base editing system not merely as a tool for gene editing but as a dynamic recorder of signaling activity within individual cells. By cleverly coupling base editor-induced mutagenesis to the magnitude of cellular signaling pathways, the system introduces genomic mutations at rates directly proportional to signaling intensity, thereby creating a permanent and quantifiable molecular signature of pathway activation. This critical advancement moves beyond snapshot fluorescent imaging or reporter assays, which often lack temporal resolution and sustainability.

One of the defining features of INSCRIBE is its novel ratiometric imaging readout strategy, utilizing dual fluorescence channels to accurately infer editing frequencies within single cells after experimental endpoint fixation. This quantitative imaging method circumvents the need for destructive sequencing techniques, preserving the spatial context of cells within tissues or cultures and allowing researchers to examine signal histories with unprecedented detail. It essentially transforms living cells into living archives of their signaling experiences.

Applying INSCRIBE to human cell models, the research team focused on two pivotal developmental signaling pathways: WNT and BMP. Both pathways are renowned for their roles in embryonic patterning, stem cell fate decisions, and the regulation of oncogenic processes. By engineering reporter cells calibrated to respond to these signals, the team conducted dose–response and time-course experiments to rigorously test the system’s accuracy in capturing signal intensity and duration. The results were strikingly congruent with expected biological behaviors, validating INSCRIBE as a powerful quantitative tool.

What makes INSCRIBE truly transformative is its ability to capture not only instantaneous pathway activity but also the “memory” of such signaling events maintained across cellular generations. In their investigations into BMP signaling, the researchers uncovered a persistent memory phenomenon: progeny derived from cells exhibiting high BMP pathway activity retained an enhanced sensitivity to subsequent BMP stimulations for up to three weeks. This finding sheds light on the epigenetic and functional plasticity of progenitor cells and could have profound implications for understanding tissue regeneration and disease relapse mechanisms.

INSCRIBE’s innovative use of CRISPR base editors detaches it from traditional gene-editing applications, opening the door to scalable, non-invasive cellular recording. The ability to record signaling intensities as genomic edits provides a stable and inheritable marker, overcoming the transient limitations faced by fluorescent reporters that can dilute or degrade over time. This leap allows researchers to revisit spatially complex samples like tissues or organoids long after initial stimulation events.

The strategic use of dual fluorescence channels to decode the editing signatures adds a quantitative depth to single-cell analysis that balances throughput and precision. Unlike bulk sequencing methods that average signals across millions of cells, the in situ imaging format preserves the heterogeneity inherent in biological systems and captures cell-to-cell variability in signal responsiveness and memory.

The versatility of INSCRIBE extends beyond developmental biology. Monitoring signaling dynamics with high fidelity at single-cell resolution offers new avenues for understanding cancer progression, immune responses, and regenerative medicine. Aberrant signaling underpins many pathologies, and the ability to map these transient events into a permanent genomic record transforms how scientists can track disease trajectories and therapeutic responses.

Moreover, INSCRIBE moves the field towards a more integrated perspective of cellular behavior, connecting transient biochemical signals to long-term functional outcomes encoded within the genome. This paradigm shift could facilitate the discovery of new regulatory mechanisms that drive cellular identities and fate decisions, with implications for stem cell biology, tissue engineering, and personalized medicine.

In terms of technical innovation, the development involved meticulous optimization of base editor kinetics to ensure mutation rates faithfully reflect signaling intensities without perturbing endogenous cellular functions. This fine-tuning required balancing editing activity with cellular viability and maintaining the integrity of pathway regulation, highlighting the sophistication of engineering at the intersection of synthetic biology and genome engineering.

Additionally, the system’s ability to distinguish exposure duration alongside intensity provides a multidimensional readout of signaling—not just “if” a pathway was activated, but for “how long” and to “what extent.” Such temporal resolution is critical in decoding signaling cascades where duration can influence opposing cellular outcomes like differentiation versus proliferation.

The discovery of signaling memory preserved through cell divisions challenges prevailing notions that signaling inputs are reset after mitosis. Instead, INSCRIBE-guided analyses suggest that certain signaling pathways leave epigenetic footprints that bias progeny toward specific responses, providing a molecular substrate for cellular “experience” influencing future behavior.

The implications of these findings extend to developmental biology, where morphogen gradients rely on nuanced signaling patterns to orchestrate complex tissue architectures. INSCRIBE’s in situ quantitative readouts promise to elucidate how individual cells interpret gradients over time to make collective decisions during organogenesis.

Looking forward, the scalability of INSCRIBE raises exciting prospects for tissue-scale mapping of signaling networks, allowing integrative studies that couple genetics, epigenetics, and signaling with spatial resolution. This is particularly relevant for probing heterogeneous tumor microenvironments or complex immune niches where single-cell behaviors define overall system dynamics.

INSCRIBE stands poised to become an indispensable tool across biological disciplines, merging real-time functional recording with the spatial and molecular granularity essential for decoding the language of cells. As researchers adopt this technology, we anticipate rapid advances in our ability to tease apart the complexity of intercellular communication in health and disease.

Overall, the work by Hao and colleagues represents a transformative leap in bioengineering—a fusion of cutting-edge gene editing, synthetic biology, and live-cell imaging to forge an enduring window into the once elusive narratives of cellular signaling memory. This innovative approach heralds a new era where the history of a cell’s internal decisions is no longer lost to time but inscribed within its very genome, accessible to probing eyes and analytical minds alike.

Subject of Research: Cellular signaling dynamics and genetic recording of single-cell signaling memory

Article Title: Genetic recording and in situ readout of single-cell signaling memory

Article References:
Hao, K., Liu, Y., Barrett, M. et al. Genetic recording and in situ readout of single-cell signaling memory. Nat Chem Biol (2026). https://doi.org/10.1038/s41589-026-02168-3

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41589-026-02168-3

Central to the investigation was the fine-mapping and genomic editing of a single nucleotide polymorphism, rs2954658, located in the RPL8 locus. This variant, a T-to-C transition, has previously been associated with elevated gene expression in B cells through extensive expression quantitative trait locus (eQTL) studies and sophisticated statistical fine-mapping analyses. The challenge was to confirm whether this variant exerts a causal regulatory effect on RPL8 expression in a controlled experimental setting, something that had remained elusive due to methodological limitations.

Leveraging the power of adenine base editors (ABE8e), researchers precisely induced the rs2954658 variant within Daudi B cells. Single-cell RNA sequencing (scRNA-seq) was performed on 969 cells that passed rigorous quality control filters, revealing a highly significant effect of the T allele on RPL8 expression, with a p-value smaller than 10^-9. This equated to a subtle but reproducible 0.9-fold change in expression, a level of modulation often masked in bulk assays. Crucially, no other individual genes exhibited a significant genotype effect after adjusting for multiple comparisons, underscoring the specificity of the variant’s influence.

The power of CRAFTseq becomes even more apparent when compared against traditional bulk RNA sequencing methods. When the same genomic edits were introduced into RPL8 and PTPRC loci and analyzed at the population level, changes in gene expression failed to reach statistical significance or biological relevance, respectively. The bulk assays were confounded by complex cellular interactions, including secretion of inflammatory cytokines and heterogeneous cell populations, which dilute genotype-specific outcomes. In contrast, the CRAFTseq approach allows direct attribution of transcriptional changes to the edited genotype within individual cells, directly controlling for environmental and cell-state variables.

Extending beyond the B cell context, the team also applied base editing to manipulate the autoimmune-associated variant rs61839660 in primary human naive CD4+ T cells. These cells were cultured under T helper 1 (TH1) or regulatory T cell (Treg) polarizing conditions to assess cell-state-specific effects. Using BE4-NG base editors, the alternative T allele was introduced in cells derived from genotyped non-autoimmune donors. Single-cell analyses discerned three distinct clusters representing varying cell states, with residual expression of IL2RA (encoding CD25) and protein surface expression changes corresponding to genotype and polarization state.

The integration of CRISPR base editing, single-cell genomics, and phenotypic profiling in this work represents a significant advance in functional genomics. By enabling cell-type and cell-state-specific resolution of variant effects, CRAFTseq addresses a major bottleneck in the field: the inability to confidently assign molecular consequences to regulatory disease variants. This precision genome editing coupled with transcriptome-wide resolution holds transformative potential for understanding the genetic basis of complex traits and diseases, including autoimmune disorders and cancer.

The technical sophistication of the study is notable. Employing different base editor variants optimized for the targeted nucleotide changes, alongside multiplexed single-cell transcriptomics and indexed flow cytometry, the researchers crafted a multifaceted experimental framework. This elaborate design allowed dissection of the consequences of single-nucleotide polymorphisms not only at the RNA expression level but also by correlating expression with cell surface protein markers. The use of linear regression and likelihood ratio tests provided rigorous statistical evaluation of genotype-expression associations at single-cell resolution, a methodological triumph.

Beyond the immediate findings, the implications of this work resonate broadly across genetics and immunology. The capacity to distinguish subtle regulatory effects in discrete immune cell subsets opens avenues for linking genotype to phenotype in a manner previously achievable only in bulk or correlative studies. The observed specificity of the rs2954658 variant effect for RPL8 alone, without off-target transcriptomic perturbations, validates the precision of the editing and the reliability of CRAFTseq in uncovering true causal relationships.

Moreover, the demonstration that bulk RNA assays can overlook or misinterpret the functional impact of genetic variants emphasizes the necessity of single-cell approaches in functional variant characterization. Cellular heterogeneity, paracrine signaling, and mix of edited and unedited cells in traditional CRISPR experiments impose confounding variables that mask direct genetic effects. CRAFTseq circumvents these pitfalls, allowing researchers to parse genetic influence from cellular context comprehensively.

This study’s methodology also sets a precedent for future investigations aiming to validate disease-associated variants identified through genome-wide association studies (GWAS) or population sequencing efforts. By coupling targeted base editing with single-cell multi-omic readouts, scientists can robustly interrogate putative causal variants in relevant primary cell types and states, bridging the gap from association to mechanism with unprecedented fidelity.

The versatility of the approach is highlighted by its successful application to both immortalized cell lines and primary human immune cells under physiologically relevant culture conditions. Polarization into TH1 and Treg states allowed assessment of variant impact within immune differentiation trajectories, a critical aspect for autoimmune disease modeling. Residual analyses linking genotype with IL2RA transcript and protein expression illustrate the power to map genotype-to-phenotype relationships across molecular layers within complex cell populations.

In closing, this pioneering work published in Nature charts a new path for precisely defining the effects of disease-associated variants directly in their cellular context. By drawing on advances in genome editing, single-cell sequencing, and statistical modeling, the authors have showcased a robust platform that promises to accelerate functional genomics and the understanding of gene regulation in health and disease. The integration of mutation induction with detailed phenotypic dissection at the single-cell level heralds a transformative era for variant interpretation, personalized medicine, and therapeutic target discovery.

Subject of Research: Functional characterization of disease-associated regulatory genetic variants through CRISPR base editing and single-cell transcriptomics.

Article Title: Precisely defining disease variant effects in CRISPR-edited single cells.

Article References:
Baglaenko, Y., Mu, Z., Curtis, M. et al. Precisely defining disease variant effects in CRISPR-edited single cells. Nature (2025). https://doi.org/10.1038/s41586-025-09313-3

Image Credits: AI Generated